These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 25080475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.
    Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL.
    Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005
    [Abstract] [Full Text] [Related]

  • 5. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
    Hirschfield GM, Chazouillères O, Drenth JP, Thorburn D, Harrison SA, Landis CS, Mayo MJ, Muir AJ, Trotter JF, Leeming DJ, Karsdal MA, Jaros MJ, Ling L, Kim KH, Rossi SJ, Somaratne RM, DePaoli AM, Beuers U.
    J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
    [Abstract] [Full Text] [Related]

  • 6. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
    Zhou M, Wang X, Phung V, Lindhout DA, Mondal K, Hsu JY, Yang H, Humphrey M, Ding X, Arora T, Learned RM, DePaoli AM, Tian H, Ling L.
    Cancer Res; 2014 Jun 15; 74(12):3306-16. PubMed ID: 24728076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Developmental regulation of the gut-liver (FGF19-CYP7A1) axis in neonates.
    Memon N, Griffin IJ, Lee CW, Herdt A, Weinberger BI, Hegyi T, Carayannopoulos MO, Aleksunes LM, Guo GL.
    J Matern Fetal Neonatal Med; 2020 Mar 15; 33(6):987-992. PubMed ID: 30122083
    [Abstract] [Full Text] [Related]

  • 9. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q, Chen XL, Wang CY, Liu Q, Sun HJ, Sun PY, Huo XK, Liu ZH, Yao JH, Liu KX.
    Toxicol Appl Pharmacol; 2015 Mar 15; 283(3):178-86. PubMed ID: 25655198
    [Abstract] [Full Text] [Related]

  • 10. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.
    Cariello M, Piccinin E, Garcia-Irigoyen O, Sabbà C, Moschetta A.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr 15; 1864(4 Pt B):1308-1318. PubMed ID: 28965883
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study.
    Uriarte I, Santamaria E, López-Pascual A, Monte MJ, Argemí J, Latasa MU, Adán-Villaescusa E, Irigaray A, Herranz JM, Arechederra M, Basualdo J, Lucena F, Corrales FJ, Rotellar F, Pardo F, Merlen G, Rainteau D, Sangro B, Tordjmann T, Berasain C, Marín JJG, Fernández-Barrena MG, Herrero I, Avila MA.
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun 15; 1870(5):167166. PubMed ID: 38642480
    [Abstract] [Full Text] [Related]

  • 15. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
    Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, Schaap FG.
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar 15; 298(3):G440-5. PubMed ID: 20093562
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Engineered FGF19ΔKLB protects against intrahepatic cholestatic liver injury in ANIT-induced and Mdr2-/- mice model.
    Shi L, Zhao T, Huang L, Pan X, Wu T, Feng X, Chen T, Wu J, Niu J.
    BMC Biotechnol; 2023 Oct 03; 23(1):43. PubMed ID: 37789318
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome.
    Johansson H, Svensson JF, Almström M, Van Hul N, Rudling M, Angelin B, Nowak G, Fischler B, Ellis E.
    J Intern Med; 2020 May 03; 287(5):534-545. PubMed ID: 31976601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.